Opaque AI systems risk undermining human rights and dignity. Global cooperation is needed to ensure protection.
The rise of artificial intelligence (AI) has changed how people interact, but it also poses a global risk to human dignity, according to new research from Charles Darwin University (CDU).
Lead author Dr. Maria Randazzo, from CDU's School of Law, explained that AI is rapidly reshaping Western legal and ethical systems, yet this transformation is eroding democratic principles and reinforcing existing social inequalities.
She noted that current regulatory frameworks often overlook basic human rights and freedoms, including privacy, protection from discrimination, individual autonomy, and intellectual property. This shortfall is largely due to the opaque nature of many algorithmic models, which makes their operations difficult to trace.
The black box problem
Dr. Randazzo described this lack of transparency as the "black box problem," noting that the decisions produced by deep-learning and machine-learning systems cannot be traced by humans. This opacity makes it challenging for individuals to understand whether and how an AI model has infringed on their rights or dignity, and it prevents them from effectively pursuing justice when such violations occur.
"This is a very significant issue that is only going to get worse without adequate regulation," Dr. Randazzo said.
"AI is not intelligent in any human sense at all. It is a triumph in engineering, not in cognitive behaviour."
"It has no clue what it's doing or why – there's no thought process as a human would understand it, just pattern recognition stripped of embodiment, memory, empathy, or wisdom."
Global approaches to AI governance
Currently, the world's three dominant digital powers – the United States, China, and the European Union – are taking markedly different approaches to AI, leaning on market-centric, state-centric, and human-centric models, respectively.
Dr. Randazzo said the EU's human-centric approach is the preferred path to protect human dignity, but without a global commitment to this goal, even that approach falls short.
"Globally, if we don't anchor AI development to what makes us human – our capacity to choose, to feel, to reason with care, to empathy and compassion – we risk creating systems that devalue and flatten humanity into data points, rather than improve the human condition," she said.
"Humankind must not be treated as a means to an end."
Reference: "Human dignity in the age of Artificial Intelligence: an overview of legal issues and regulatory regimes" by Maria Salvatrice Randazzo and Guzyal Hill, 23 April 2025, Australian Journal of Human Rights.
DOI: 10.1080/1323238X.2025.2483822
The paper is the first in a trilogy Dr. Randazzo will produce on the topic.
News
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
